Latest On Koninklijke DSM N.V (KDSKF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-08 19:03 EST | News | Royal DSM: Significant Execution Risk | N/A |  |
| 2023-02-21 18:45 EST | News | Royal DSM 2022 Results: Better Than Feared | N/A | |
| 2023-02-16 21:19 EST | News | Koninklijke DSM N.V. reports FY results | N/A | |
| 2023-02-16 21:19 EST | News | Koninklijke DSM N.V. (KDSKF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-16 21:19 EST | News | Koninklijke DSM N.V. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-11-16 21:21 EST | News | Royal DSM Q3 Results: Good Organic Sales Growth, But Inflation Is Impacting Earnings | N/A | |
| 2022-09-07 10:34 EST | News | Royal DSM: Transformation Almost Complete, Shares Attractively Priced | N/A | |
| 2022-08-23 20:44 EST | News | Royal DSM: Quality At A Price | N/A | |
| 2022-08-04 05:58 EST | Dividend | A dividend of $0.93 has been announced on Aug 2, 2022. It will be paid Aug 26, 2022 with an ex-dividend date of Aug 4, 2022. | Neutral | |
| 2022-08-03 00:01 EST | News | Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 14:42 EST | News | DSM NV: Staying Resilient Through The Downcycle | N/A | |
| 2022-02-15 14:39 EST | News | Koninklijke DSM N.V. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-15 14:39 EST | News | Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-10 06:02 EST | Dividend | A dividend of $1.6 has been announced on May 4, 2021. It will be paid Jun 1, 2021 with an ex-dividend date of May 10, 2021. | Neutral | |
| 2021-02-23 05:08 EST | Earnings Estimate | An EPS average of $1.56 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-02-23 05:08 EST | Earnings Estimate | An EPS average of $1.58 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2021-02-18 21:10 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-17 13:08 EST | News | Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-17 05:09 EST | Earnings Estimate | An EPS average of $6.48 is estimated for the 2022 year. | Buy | |
| 2021-02-16 19:48 EST | News | Koninklijke DSM N.V. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-11-26 22:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-04 17:23 EST | News | Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-04 13:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 15:23 EST | News | Koninklijke DSM N.V. 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-09-26 14:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 02:48 EST | News | Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-07 14:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 05:59 EST | Dividend | A dividend of $0.8 has been announced on Aug 5, 2020. It will be paid Aug 28, 2020 with an ex-dividend date of Aug 6, 2020. | Neutral | |
| 2020-08-06 04:37 EST | News | Koninklijke DSM N.V. 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-07-30 18:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 02:20 EST | Earnings Estimate | An EPS average of $1.25 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-05-27 07:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-20 14:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-17 14:11 EST | Financials | Company financials have been released. | Neutral | |
About Koninklijke DSM N.V (KDSKF):
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
General
- Name Koninklijke DSM N.V
- Symbol KDSKF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorBasic Materials
- IndustrySpecialty Chemicals
- Full Time Employees 21,313
- Fiscal Year EndDecember
- Web URLhttp://www.dsm.com
Valuation
- Trailing PE 25.73
- Forward PE 28.65
- Price/Sales (Trailing 12 Mt.) 3
- Price/Book (Most Recent Quarter) 3.28
- Enterprise Value Revenue 3.96
- Enterprise Value EBITDA 22.4
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $5.87
- Next Year EPS Estimate $6.55
- Profit Margin 6%
- Return on Assets 3%
- Return on Equity 6%
- Earnings Per Share $6.53
- Revenue Per Share $0
- Gross Profit 2.78 billion
- Quarterly Earnings Growth -3.3%
ESG Rating
Highlights
- Market Capitalization 28.92 billion
- PEG Ratio 3.68
- Book Value Per Share $50.32
Share Statistics
- Shares Outstanding 172.45 million
- Shares Float 172.21 million
- % Held by Insiders 32%
- % Held by Institutions 48.84%
Technicals
- Beta 0.6
- 52 Week High $182.25
- 52 Week Low $98.59
- 50 Day Moving Average 173.11
- 200 Day Moving Average 168.44
Dividends
- Forward Annual Dividend Rate $2.77
- Forward Annual Dividend Yield 1.65%
- Payout Ratio 70%
- Dividend Date 2020-06-03
- ExDividend Date 2020-08-06
- Dividend Per Share $2.38
- Dividend Yield 0%
Koninklijke DSM N.V (KDSKF) Dividend Calendar:
KDSKF's last dividend payment was made to shareholders on June 3, 2020.
Koninklijke DSM N.V pays out 70% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Koninklijke DSM N.V (KDSKF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $1.17 | $1.30 | -10% |
| 2020-09-30 | 2020-12-31 | $N/A | $0.36 | $1.05 | -65.54% |
| 2020-06-30 | 2020-09-30 | $2.24 billion | $1.13 | $1.07 | 5.25% |
| 2020-03-31 | 2020-05-07 | $2.29 billion | $1.24 | $1.05 | 18.1% |
| 2019-12-31 | 2020-03-31 | $2.41 billion | $1.06 | $1.05 | 1.04% |
| 2019-09-30 | 2019-12-31 | $2.5 billion | $0.78 | $1.19 | -34.65% |
| 2019-06-30 | 2019-09-30 | $2.57 billion | $1.31 | $1.24 | 5.77% |
| 2019-03-31 | 2019-05-07 | $2.57 billion | $1.12 | $1.15 | -2.61% |
| 2018-12-31 | 2019-03-31 | $2.53 billion | $1.23 | $1.09 | 12.79% |
| 2018-09-30 | 2018-12-31 | $2.62 billion | $1.67 | $1.19 | 40.08% |
| 2018-06-30 | 2018-09-30 | $2.75 billion | $1.23 | $1.65 | -25.52% |
| 2018-03-31 | 2018-06-30 | $3 billion | $1.99 | $1.68 | 18.62% |
| 2017-12-31 | 2018-03-31 | $2.61 billion | $2.31 | $1.03 | 124.41% |
| 2017-09-30 | 2017-12-31 | $2.51 billion | $1.18 | $0.94 | 25.07% |
| 2017-06-30 | 2017-09-30 | $2.47 billion | $8.69 | $0.97 | 795.53% |
| 2017-03-31 | 2017-06-30 | $2.31 billion | $1.04 | $0.76 | 36.63% |
| 2016-12-31 | 2017-03-31 | $1.72 billion | $0.90 | $0.74 | 21.04% |
| 2016-09-30 | 2016-12-31 | $0.51 | $0.89 | -42.29% | |
| 2016-06-30 | 2016-09-30 | $2.21 | $0.70 | 216.19% | |
| 2016-03-31 | 2016-06-30 | $0.84 | $0.57 | 47.63% | |
| 2015-12-31 | 2016-03-31 | $0.53 | $0.48 | 10% | |
| 2015-09-30 | 2015-11-03 | $0.70 | $0.68 | 2.94% | |
| 2015-06-30 | 2015-09-30 | $0.20 | $0.69 | -70.33% | |
| 2015-03-31 | 2015-06-30 | $0.46 | $0.54 | -14.83% | |
| 2014-12-31 | 2015-03-31 | $0.25 | $0.69 | -63.23% | |
| 2014-09-30 | 2014-11-04 | $0.81 | $0.74 | 9.46% | |
| 2014-06-30 | 2014-09-30 | $0.58 | $0.69 | -15.32% | |
| 2014-03-31 | 2014-06-30 | $0.58 | $0.46 | 26.76% | |
| 2013-12-31 | 2014-03-31 | $0.39 | $0.85 | -54.04% | |
| 2013-09-30 | 2013-09-30 | $0.89 | |||
| 2013-06-30 | 2013-09-30 | $0.83 | |||
| 2013-03-31 | 2013-06-30 | $0.89 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.90 | |||
| 2012-06-30 | 2012-09-30 | $0.60 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.30 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $1.16 | |||
| 2011-09-30 | 2011-12-31 | $1.49 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $1.36 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $2.41 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $1.24 | $0.00 | ||
| 2009-12-31 | 2009-12-31 | -$0.54 |
Koninklijke DSM N.V (KDSKF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Koninklijke DSM N.V (KDSKF) Chart:
Koninklijke DSM N.V (KDSKF) News:
Below you will find a list of latest news for Koninklijke DSM N.V (KDSKF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Koninklijke DSM N.V (KDSKF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Koninklijke DSM N.V (KDSKF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|